Regenexx maintains an active patient registry that consistently follows up with patients regarding their progress and any potential side effects post-procedure. The extensive registry encompasses tens of thousands of Regenexx procedures conducted by physicians within our network, forming a comprehensive outcomes database. Regenexx is the only company tracking such a large orthopedic patient population treated with bone marrow concentrate.

In our commitment to transparency with prospective patients, we openly share procedure outcomes on our website. This allows patients to view the number of procedures tracked and the reported results firsthand. With Regenexx, patients gain access to information necessary for making a well-informed decision about the best treatment option for their needs.

5,600+ Regenexx Neck Patients

48%

48% of patients saw an overall improvement after just three months

88%

Up to 88% of patients regained their average function

33%

33% of patients reported a decrease in joint pain after just one month

1,600+ Regenexx Elbow Patients

54%

54% of patients saw an overall improvement after just three months

97%

Up to 97% of patients regained their average function

34%

34% of patients reported a decrease in joint pain after just one month

3,700+ Regenexx Foot and Ankle Patients

47%

47% of patients saw an overall improvement after just three months

79%

Up to 79% of patients regained their average function

33%

33% of patients reported a decrease in joint pain after just one month

2,700+ Regenexx Hand and Wrist Patients

46%

46% of patients saw an overall improvement after just three months

88%

88% of patients report a decrease in joint pain after just one month

32%

32% of patients reported a decrease in joint pain after just one month

5,700+ Regenexx Hip Patients

45%

45% of patients saw overall improvement after just three months

76%

Up to 76% of patients regained their average function

30%

30% of patients reported a decrease in joint pain after just one month

20,000+ Regenexx Knee Patients

51%

51% of patients saw an overall improvement after just three months

76%

Up to 76% of patients regained their average function

43%

43% of patients reported a decrease in joint pain after just one month

15,300+ Regenexx Back Patients

45%

45% of patients saw an overall improvement after just three months

73%

Up to 73% of patients regained their average function

28%

28% of patients reported a decrease in joint pain after just one month

7,700+ Regenexx Shoulder Patients

51%

51% of patients saw an overall improvement after just three months

88%

Up to 88% of patients regained their average function

34%

34% of patients reported a decrease in joint pain after just one month